Allianz Asset Management Gmb H Myriad Genetics Inc Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$17.59 - $23.59 $133,684 - $179,284	-7,600 Reduced 31.8%	16,300 $347,000
Q4 2023 Feb 12, 2024	SELL	$13.91 - $21.32 $16,692 - $25,584	-1,200 Reduced 4.78%	23,900 $457,000
Q3 2023 Nov 13, 2023	BUY	$15.99 - $23.22 $401,349 - $582,822	25,100 New	25,100 $402,000
Q1 2023 May 11, 2023	BUY	$15.26 - $23.75 $274,420 - $427,096	17,983 Added 5.42%	350,014 $8.13 Million
Q4 2022 Feb 13, 2023	BUY	$14.51 - $20.99 $393,221 - $568,829	27,100 Added 8.89%	332,031 $4.82 Million
Q3 2022 Nov 08, 2022	BUY	$18.21 - $27.88 $1.87 Million - $2.86 Million	102,677 Added 50.77%	304,931 $5.82 Million
Q2 2022 Aug 12, 2022	BUY	$16.45 - $25.88 $725,625 - $1.14 Million	44,111 Added 27.89%	202,254 $3.68 Million
Q1 2022 May 13, 2022	BUY	$22.67 - $28.01 $784,177 - $968,893	34,591 Added 28.0%	158,143 $3.99 Million
Q4 2021 Feb 11, 2022	SELL	$24.13 - $32.63 $190,627 - $257,777	-7,900 Reduced 6.01%	123,552 $3.41 Million
Q3 2021 Nov 10, 2021	BUY	$29.97 - $36.66 $3.94 Million - $4.82 Million	131,452 New	131,452 $4.25 Million
Q1 2020 May 14, 2020	SELL	$9.78 - $29.53 $217,536 - $656,835	-22,243 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$20.93 - $35.1 $2,365 - $3,966	-113 Reduced 0.51%	22,243 $605,000
Q3 2019 Nov 13, 2019	SELL	$22.08 - $47.08 $759,044 - $1.62 Million	-34,377 Reduced 60.59%	22,356 $640,000
Q2 2019 Aug 08, 2019	SELL	$22.67 - $35.0 $626,304 - $966,945	-27,627 Reduced 32.75%	56,733 $1.58 Million
Q1 2019 May 13, 2019	BUY	$26.93 - $34.7 $1.09 Million - $1.41 Million	40,584 Added 92.71%	84,360 $2.8 Million
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $2.75 Million - $4.6 Million	-101,047 Reduced 69.77%	43,776 $1.27 Million
Q3 2018 Nov 13, 2018	SELL	$37.57 - $50.34 $16.1 Million - $21.5 Million	-427,948 Reduced 74.72%	144,823 $6.66 Million
Q2 2018 Aug 13, 2018	SELL	$27.75 - $40.17 $1.04 Million - $1.5 Million	-37,419 Reduced 6.13%	572,771 $21.4 Million
Q1 2018 May 14, 2018	BUY	$28.83 - $41.01 $3.61 Million - $5.13 Million	125,172 Added 25.81%	610,190 $18 Million
Q4 2017 Feb 13, 2018	BUY	$28.45 - $37.14 $13.5 Million - $17.6 Million	473,745 Added 4202.47%	485,018 $16.7 Million
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $15,966 - $24,073	665 Added 6.27%	11,273 $408,000
Q2 2017 Aug 14, 2017	BUY	N/A	515 Added 5.1%	10,608 $272,000
Q1 2017 Apr 17, 2019	SELL	N/A	-1,154 Reduced 10.26%	10,093 $194,000
Q3 2016 Apr 17, 2019	BUY	N/A	11,247	11,247 $233,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$208 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$142 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$92.3 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$71.1 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$64.6 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account